| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| eResearchTechnology, Inc. |
| 30 south 17th Street, Philadelphia, PA 19103 * (215) 972-0420 |
| Business Description | The company is a business-to-business provider of integrated software applications and technology consulting services to the pharmaceutical, biotechnology and medical device industries. |
|
Filing Information IPO has been | |||
| To Trade As | ERES (NASNTL) | Industry | Internet (SIC 7389) |
| Type of Stock Offered | Common Shares | Filing Date | 3/29/2000 |
| Domestic Shares Filed | 4,000,000 | Filing Range | $10.00 - $12.00 |
| Foreign Shares Filed | 0 | Offering Amount | $44,000,000 |
| Company Shares | 4,000,000 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| SG Cowen | Lead Manager | (212) 495-6000 |
| Prudential Vector Healthcare | Co-manager | (800) 546-1231 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | - - Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1997 | 12/31/1998 | 12/31/1999 | ||||
| Revenues | - | - | 14.163 | 31.807 | 42.785 | - | - |
| Income from Oper. | - | - | - | - | - | - | - |
| Net Income | - | - | 6.988 | 0.125 | 1.929 | - | - |
| E.P.S | - | - | - | - | - | - | - |
| Revenue Growth (%) | - | - | 124.58 | 34.514 | - | ||
| Net Income Growth (%) | - | - | -98.21 | 1,443.20 | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | 49.34 | 0.39 | 4.51 | - | - |
| Cash Flow - Oper. | 8.11 | - | - | ||||
| Cash Flow - Inv. | -2.24 | - | - | ||||
| Cash Flow - Fin. | -5.87 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 12/31/1999 | Financial Ratios | ||||
| Total Assets | 13.33 | Current Assets | 5.86 | Current Ratio | 0.73 |
| Total Liab. | 8.06 | Current Liab. | 8.06 | Debt Ratio | 60.51% |
| Total Equity | 5.26 | Working Cap. | -2.20 | Debt to Equity Ratio | 1.53 |
| Cash | - | Return on Assets | 14.48% | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for product development, sales and marketing, capital expenditures, working capital and general corporate purposes which may include strategic acquisitions or the establishment of strategic alliances. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Duane, Morris & Heckscher |
| Bank's Law Firm | Alston & Bird |
| Registrar/Transfer Agent | First Union National Bank North Carolina |
| Auditor | Arthur Andersen |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Premier Research Worldwide | 100.00 | |
| Note: represents ownership of 5% or more prior to the offering. | ||